Kees van Bergen
Kees van Bergen
Leiden University Medical Center
Verified email at ziggo.nl - Homepage
Title
Cited by
Cited by
Year
Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes
JHF Falkenburg, AR Wafelman, P Joosten, WM Smit, CAM van Bergen, ...
Blood, The Journal of the American Society of Hematology 94 (4), 1201-1208, 1999
3551999
Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells
WM Smit, M Rijnbeek, CAM van Bergen, RA de Paus, HAW Vervenne, ...
Human immunology 53 (2), 216-223, 1997
1131997
High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning
CAM Van Bergen, CE Rutten, ED Van Der Meijden, ...
Cancer research 70 (22), 9073-9083, 2010
1122010
Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene
CAM van Bergen, MGD Kester, I Jedema, MHM Heemskerk, ...
Blood 109 (9), 4089-4096, 2007
1082007
T cells recognizing leukemic CD34+ progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem …
WM Smit, M Rijnbeek, CAM Van Bergen, WE Fibbe, R Willemze, ...
Proceedings of the National Academy of Sciences 95 (17), 10152-10157, 1998
961998
Identification of 4 new HLA-DR–restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity
AN Stumpf, ED van der Meijden, CAM van Bergen, R Willemze, ...
Blood, The Journal of the American Society of Hematology 114 (17), 3684-3692, 2009
892009
Autosomal minor histocompatibility antigens: how genetic variants create diversity in immune targets
M Griffioen, CAM van Bergen, JH Falkenburg
Frontiers in immunology 7, 100, 2016
792016
HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion
S Stevanović, CAM van Bergen, SAP van Luxemburg-Heijs, ...
Blood, The Journal of the American Society of Hematology 122 (11), 1963-1973, 2013
792013
Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response
CAM van Bergen, SAP van Luxemburg-Heijs, LC de Wreede, M Eefting, ...
The Journal of clinical investigation 127 (2), 517-529, 2017
772017
Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma
D Schneider, M Dühren-von Minden, A Alkhatib, C Setz, CAM van Bergen, ...
Blood, The Journal of the American Society of Hematology 125 (21), 3287-3296, 2015
662015
Allo-HLA–reactive T cells inducing graft-versus-host disease are single peptide specific
AL Amir, DM van der Steen, RS Hagedoorn, MGD Kester, ...
Blood, The Journal of the American Society of Hematology 118 (26), 6733-6742, 2011
652011
Patient HLA-DP–Specific CD4+ T Cells from HLA-DPB1–Mismatched Donor Lymphocyte Infusion Can Induce Graft-versus-Leukemia Reactivity in the Presence or Absence of Graft-versus …
CE Rutten, SAP van Luxemburg-Heijs, CJM Halkes, CAM van Bergen, ...
Biology of Blood and Marrow Transplantation 19 (1), 40-48, 2013
562013
Phase I/II feasibility study evaluating the generation of leukemia-reactive cytotoxic T lymphocyte lines for treatment of patients with relapsed leukemia after allogeneic stem …
E Marijt, A Wafelman, M van der Hoorn, C van Bergen, R Bongaerts, ...
haematologica 92 (1), 72-80, 2007
552007
Generation of leukemia-reactive cytotoxic T lymphocytes from HLA-identical donors of patients with chronic myeloid leukemia using modifications of a limiting dilution assay
WM Smit, M Rijnbeek, CAM Van Bergen, R Willemze, JHF Falkenburg
Bone marrow transplantation 21 (6), 553-560, 1998
421998
Identification of 4 novel HLA-B* 40: 01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity
M Griffioen, MW Honders, ED van der Meijden, SAP van Luxemburg-Heijs, ...
Haematologica 97 (8), 1196, 2012
412012
Proteosomal degradation of BCR/ABL protein can generate an HLA-A* 0301-restricted peptide, but high-avidity T cells recognizing this leukemia-specific antigen were not demonstrated
EF Posthuma, CA Van Bergen, MG Kester, RA de Paus, PA van Veelen, ...
haematologica 89 (9), 1062-1071, 2004
362004
Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach
P Hombrink, C Hassan, MGD Kester, AH de Ru, CAM van Bergen, ...
The Journal of Immunology 190 (8), 3869-3877, 2013
342013
CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation
CHJ Lamers, R Wijers, CAM van Bergen, JAE Somers, E Braakman, ...
Blood, The Journal of the American Society of Hematology 128 (17), 2165-2174, 2016
312016
IGLV3-21* 01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling
PC Maity, M Bilal, MT Koning, M Young, CAM Van Bergen, V Renna, ...
Proceedings of the National Academy of Sciences 117 (8), 4320-4327, 2020
272020
ARTISAN PCR: rapid identification of full-length immunoglobulin rearrangements without primer binding bias.
MT Koning, SM Kiełbasa, V Boersma, HPJ Buermans, SAJ van der Zeeuw, ...
British journal of haematology 178 (6), 983-986, 2016
242016
The system can't perform the operation now. Try again later.
Articles 1–20